Formulation of Anti-Wrinkle Cream from Total Extract of Glycine Max and Equisetum Arvense

Formulation of Anti-Wrinkle Cream from Total Extract of Glycine Max and Equisetum Arvense for Treatment of Mild to Moderate Facial Wrinkles in 30-50 Year Old Individuals (Male and Female)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190917044799N1

Enrollment

Registered

2019-09-28

Start date

2018-09-20

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate facial wrinkles.

Interventions

Intervention group: The treatment group consist of 30_40 patients receiving Glycin Max and Equisetum Arvens daily for 6 months.

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having mild to moderate wrinkles Age between 30 to 50 years The ability to understand and sign the consent form

Exclusion criteria

Exclusion criteria: Having severe wrinkles and dermal problems like inflammation and acne Pregnancy and lactation Vulnerable people and groups such as children and mental disorders People with specific illnesses

Design outcomes

Primary

Measure	Time frame
Number of wrinkles,depths and lengths of wrinkles and exact location of wrinkles. Timepoint: Once a month. Method of measurement: Visual analogue scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYousef Javadzadeh

Tabriz University of Medical Sciences

javadzadehy@yahoo.com+98 41 3230 5153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026